แนวคิดหลัก
Effective testosterone replacement therapy can significantly improve the quality of life and health of patients with low testosterone levels, despite existing misconceptions and challenges.
บทคัดย่อ
Introduction
Treating low testosterone levels in France poses challenges due to underdiagnosis, doctor reluctance, and patient misconceptions.
Dr. Eric Huygue emphasizes the benefits of replacement therapy for improving quality of life and health.
Testosterone Levels
Symptoms of testosterone deficiency affect men over 40, impacting sexual, physical, and mental health.
Only 20% of symptomatic men in France receive replacement therapy due to underdiagnosis and reluctance.
Certain conditions and medications can lead to low testosterone levels.
Diagnosis and Treatment
Diagnosis should be based on free or bioavailable testosterone levels, not total testosterone.
Reference ranges based on age group contribute to underdiagnosis.
Doctors may be hesitant to prescribe replacement therapy due to perceived risks, especially related to prostate cancer.
Prostate Cancer Concerns
Urologists are cautious about prescribing testosterone to patients with a history of prostate cancer.
Studies show that testosterone replacement therapy is safe post-prostatectomy or radiotherapy.
Testosterone does not increase the risk of prostate cancer recurrence.
Cardiovascular Benefits
Concerns about cardiovascular risks associated with testosterone have been debated.
European studies suggest cardiovascular benefits of testosterone replacement therapy.
Patients often have misconceptions about testosterone treatment, leading to reluctance.
Supply Chain Issues
Breaks in the supply chain of Androtardyl complicate the prescription and use of testosterone replacement therapy in France.
Different formulations of testosterone replacement therapies are available in the market.
สถิติ
About 20% of patients with symptomatic low testosterone levels are treated for the deficiency.
There are an estimated 340,000 men with symptomatic testosterone deficiency in France.
77% of urologists refer to reference ranges for patients of the same age.
40% of urologists think that testosterone is contraindicated in patients with a history of prostate cancer.
คำพูด
"Treatment for low testosterone is effective and risk-free. It improves a patient's quality of life and general health." - Dr. Eric Huygue
"This is a time of many surprising discoveries concerning the link between the prostate and testosterone." - Dr. Eric Huygue